BE-66-GV20_1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=1uM, Pipamperone, 5-HT2 Antagonists;Dopamine D2 Antagonists targeting HTR1E, HTR1F (Novartis, 4830)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/4830
Similar Terms
Downloads & Tools

Genes

14 genes differentially expressed following the BE-66-GV20_1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
RPS9 ribosomal protein S9 0.701478
CDC20 cell division cycle 20 0.484311
TNNT1 troponin T type 1 (skeletal, slow) 0.454699
RPL36 ribosomal protein L36 0.402603
COPZ1 coatomer protein complex, subunit zeta 1 0.402603
RHOG ras homolog family member G 0.402603
VAPA VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa 0.34231
NDUFS5 NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase) 0.284701
PCBP2 poly(rC) binding protein 2 0.235482
FBL fibrillarin 0.235482
PGP phosphoglycolate phosphatase 0.228631

decreased expression

Symbol Name Standardized Value
TGFBR2 transforming growth factor, beta receptor II (70/80kDa) -0.332544
SLC25A25 solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 25 -0.326525
EMID1 EMI domain containing 1 -0.206856